Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 26 entries
Sorted by: Best Match Show Resources per page
[[Current approaches to diagnosing and treating nonalcoholic fatty liver disease].

Terapevticheskii arkhiv

Drapkina OM, Deeva TA, Volkova NP, Ivashkin VT.
PMID: 25509904
Ter Arkh. 2014;86(10):116-23.

Nonalcoholic fatty liver disease (NAFLD) is associated with major cardiovascular risk factors, such as type 2 diabetes mellitus, obesity, dyslipidemia, hypertension, and insulin resistance, and has been recently considered to be a new component of metabolic syndrome and it...

Cite
Drapkina OM, Deeva TA, Volkova NP, et al. [[Current approaches to diagnosing and treating nonalcoholic fatty liver disease]. Ter Arkh. 2014;86(10):116-23
Drapkina, O. M., Deeva, T. A., Volkova, N. P., & Ivashkin, V. T. (2014). [[Current approaches to diagnosing and treating nonalcoholic fatty liver disease]. Terapevticheskii arkhiv, 86(10), 116-23.
Drapkina, O M, et al. "[[Current approaches to diagnosing and treating nonalcoholic fatty liver disease]." Terapevticheskii arkhiv vol. 86,10 (2014): 116-23.
Drapkina OM, Deeva TA, Volkova NP, Ivashkin VT. [[Current approaches to diagnosing and treating nonalcoholic fatty liver disease]. Ter Arkh. 2014;86(10):116-23. Russian. PMID: 25509904.
Copy Download .nbib Format: NLM
Cell-Free Circulating Nucleic Acids as Early Biomarkers for NAFLD and NAFLD-Associated Disorders.

Frontiers in physiology

Turchinovich A, Baranova A, Drapkina O, Tonevitsky A.
PMID: 30294278
Front Physiol. 2018 Sep 20;9:1256. doi: 10.3389/fphys.2018.01256. eCollection 2018.

Non-alcoholic fatty liver disease (NAFLD) is the worldwide most common cause of chronic liver pathology, which prevalence strongly correlates with the increasing incidence of diabetes, obesity and metabolic syndrome in the general population. Simple steatosis, the earliest NAFLD stage,...

Cite
Turchinovich A, Baranova A, Drapkina O, et al. Cell-Free Circulating Nucleic Acids as Early Biomarkers for NAFLD and NAFLD-Associated Disorders. Front Physiol. 2018;9:1256doi: 10.3389/fphys.2018.01256.
Turchinovich, A., Baranova, A., Drapkina, O., & Tonevitsky, A. (2018). Cell-Free Circulating Nucleic Acids as Early Biomarkers for NAFLD and NAFLD-Associated Disorders. Frontiers in physiology, 91256. https://doi.org/10.3389/fphys.2018.01256
Turchinovich, Andrey, et al. "Cell-Free Circulating Nucleic Acids as Early Biomarkers for NAFLD and NAFLD-Associated Disorders." Frontiers in physiology vol. 9 (2018): 1256. doi: https://doi.org/10.3389/fphys.2018.01256
Turchinovich A, Baranova A, Drapkina O, Tonevitsky A. Cell-Free Circulating Nucleic Acids as Early Biomarkers for NAFLD and NAFLD-Associated Disorders. Front Physiol. 2018 Sep 20;9:1256. doi: 10.3389/fphys.2018.01256. eCollection 2018. PMID: 30294278; PMCID: PMC6158334.
Copy Download .nbib Format: NLM
Case Report: Hypertriglyceridemia and Premature Atherosclerosis in a Patient With Apolipoprotein E Gene ε.

Frontiers in cardiovascular medicine

Limonova AS, Ershova AI, Meshkov AN, Kiseleva AV, Divashuk MG, Kutsenko VA, Drapkina OM.
PMID: 33537346
Front Cardiovasc Med. 2021 Jan 18;7:585779. doi: 10.3389/fcvm.2020.585779. eCollection 2020.

We present a case of a 40-year-old male with premature atherosclerosis, with evidence of both eruptive and tendinous xanthomas, which could imply an increase in both low-density lipoprotein (LDL) and triglyceride (TG) levels. However, his LDL was 2.08 mmol/l,...

Cite
Limonova AS, Ershova AI, Meshkov AN, et al. Case Report: Hypertriglyceridemia and Premature Atherosclerosis in a Patient With Apolipoprotein E Gene ε. Front Cardiovasc Med. 2021;7:585779doi: 10.3389/fcvm.2020.585779.
Limonova, A. S., Ershova, A. I., Meshkov, A. N., Kiseleva, A. V., Divashuk, M. G., Kutsenko, V. A., & Drapkina, O. M. (2020). Case Report: Hypertriglyceridemia and Premature Atherosclerosis in a Patient With Apolipoprotein E Gene ε. Frontiers in cardiovascular medicine, 7585779. https://doi.org/10.3389/fcvm.2020.585779
Limonova, Alena S, et al. "Case Report: Hypertriglyceridemia and Premature Atherosclerosis in a Patient With Apolipoprotein E Gene ε." Frontiers in cardiovascular medicine vol. 7 (2020): 585779. doi: https://doi.org/10.3389/fcvm.2020.585779
Limonova AS, Ershova AI, Meshkov AN, Kiseleva AV, Divashuk MG, Kutsenko VA, Drapkina OM. Case Report: Hypertriglyceridemia and Premature Atherosclerosis in a Patient With Apolipoprotein E Gene ε. Front Cardiovasc Med. 2021 Jan 18;7:585779. doi: 10.3389/fcvm.2020.585779. eCollection 2020. PMID: 33537346; PMCID: PMC7847930.
Copy Download .nbib Format: NLM
A Data-Driven Approach to Carrier Screening for Common Recessive Diseases.

Journal of personalized medicine

Kiseleva AV, Klimushina MV, Sotnikova EA, Divashuk MG, Ershova AI, Skirko OP, Kurilova OV, Zharikova AA, Khlebus EY, Efimova IA, Pokrovskaya MS, Slominsky PA, Shalnova SA, Meshkov AN, Drapkina OM.
PMID: 32971794
J Pers Med. 2020 Sep 22;10(3). doi: 10.3390/jpm10030140.

Genetic screening is an advanced tool for reducing recessive disease burden. Nowadays, it is still unclear as to the number of genes or their variants that are necessary for effective screening. This paper describes the development of a carrier...

Cite
Kiseleva AV, Klimushina MV, Sotnikova EA, et al. A Data-Driven Approach to Carrier Screening for Common Recessive Diseases. J Pers Med. 2020;10(3)doi: 10.3390/jpm10030140.
Kiseleva, A. V., Klimushina, M. V., Sotnikova, E. A., Divashuk, M. G., Ershova, A. I., Skirko, O. P., Kurilova, O. V., Zharikova, A. A., Khlebus, E. Y., Efimova, I. A., Pokrovskaya, M. S., Slominsky, P. A., Shalnova, S. A., Meshkov, A. N., & Drapkina, O. M. (2020). A Data-Driven Approach to Carrier Screening for Common Recessive Diseases. Journal of personalized medicine, 10(3), . https://doi.org/10.3390/jpm10030140
Kiseleva, Anna V, et al. "A Data-Driven Approach to Carrier Screening for Common Recessive Diseases." Journal of personalized medicine vol. 10,3 (2020). doi: https://doi.org/10.3390/jpm10030140
Kiseleva AV, Klimushina MV, Sotnikova EA, Divashuk MG, Ershova AI, Skirko OP, Kurilova OV, Zharikova AA, Khlebus EY, Efimova IA, Pokrovskaya MS, Slominsky PA, Shalnova SA, Meshkov AN, Drapkina OM. A Data-Driven Approach to Carrier Screening for Common Recessive Diseases. J Pers Med. 2020 Sep 22;10(3). doi: 10.3390/jpm10030140. PMID: 32971794; PMCID: PMC7563953.
Copy Download .nbib Format: NLM
[Nutrition status and obesity paradox in chronic obstructive pulmonary disease].

Voprosy pitaniia

Drapkina OM, Avdeev SN, Budnevsky AV, Ovsyannikov ES, Kontsevaya AV, Drobysheva ES.
PMID: 35032123
Vopr Pitan. 2021;90(6):42-49. doi: 10.33029/0042-8833-2021-90-6-42-49. Epub 2021 Oct 26.

Chronic obstructive pulmonary disease (COPD) is one of the main causes of increasing morbidity and mortality worldwide, and therefore is becoming a major public health problem.

Cite
Drapkina OM, Avdeev SN, Budnevsky AV, et al. [Nutrition status and obesity paradox in chronic obstructive pulmonary disease]. Vopr Pitan. 2021;90(6):42-49doi: 10.33029/0042-8833-2021-90-6-42-49.
Drapkina, O. M., Avdeev, S. N., Budnevsky, A. V., Ovsyannikov, E. S., Kontsevaya, A. V., & Drobysheva, E. S. (2021). [Nutrition status and obesity paradox in chronic obstructive pulmonary disease]. Voprosy pitaniia, 90(6), 42-49. https://doi.org/10.33029/0042-8833-2021-90-6-42-49
Drapkina, O M, et al. "[Nutrition status and obesity paradox in chronic obstructive pulmonary disease]." Voprosy pitaniia vol. 90,6 (2021): 42-49. doi: https://doi.org/10.33029/0042-8833-2021-90-6-42-49
Drapkina OM, Avdeev SN, Budnevsky AV, Ovsyannikov ES, Kontsevaya AV, Drobysheva ES. [Nutrition status and obesity paradox in chronic obstructive pulmonary disease]. Vopr Pitan. 2021;90(6):42-49. doi: 10.33029/0042-8833-2021-90-6-42-49. Epub 2021 Oct 26. Russian. PMID: 35032123.
Copy Download .nbib Format: NLM
[Place of vitamin D in the prevention of premature aging and the development of age-associated diseases].

Terapevticheskii arkhiv

Drapkina OM, Shepel RN, Fomin VV, Svistunov AA.
PMID: 32598654
Ter Arkh. 2018 Jan 15;90(1):69-75. doi: 10.17116/terarkh201890169-75.

There is an ongoing search for the molecular and biochemical mechanisms underlying the development of aging and age-associated diseases. At the same time there is growing evidence geroprotective properties of vitamin D.In this review, described in detail the possible...

Cite
Drapkina OM, Shepel RN, Fomin VV, et al. [Place of vitamin D in the prevention of premature aging and the development of age-associated diseases]. Ter Arkh. 2018;90(1):69-75doi: 10.17116/terarkh201890169-75.
Drapkina, O. M., Shepel, R. N., Fomin, V. V., & Svistunov, A. A. (2018). [Place of vitamin D in the prevention of premature aging and the development of age-associated diseases]. Terapevticheskii arkhiv, 90(1), 69-75. https://doi.org/10.17116/terarkh201890169-75
Drapkina, O M, et al. "[Place of vitamin D in the prevention of premature aging and the development of age-associated diseases]." Terapevticheskii arkhiv vol. 90,1 (2018): 69-75. doi: https://doi.org/10.17116/terarkh201890169-75
Drapkina OM, Shepel RN, Fomin VV, Svistunov AA. [Place of vitamin D in the prevention of premature aging and the development of age-associated diseases]. Ter Arkh. 2018 Jan 15;90(1):69-75. doi: 10.17116/terarkh201890169-75. Russian. PMID: 32598654.
Copy Download .nbib Format: NLM
[Optimal Control Strategy Allies in Blood Pressure].

Kardiologiia

Drapkina O M, Eliashevich S O.
PMID: 28294850
Kardiologiia. 2015 Mar;55(3):106-114. doi: 10.18565/cardio.2015.3.106-114.

OBJECTIVE: to review the available results of clinical trials on the efficacy and safety of a fixed combination of an angiotensin-converting enzyme (ACE) inhibitor lisinopril and the calcium antagonist amlodipine, including an analysis of the actual antihypertensive effect and...

Cite
Drapkina O M, Eliashevich S O. [Optimal Control Strategy Allies in Blood Pressure]. Kardiologiia. 2015;55(3):106-114doi: 10.18565/cardio.2015.3.106-114.
Drapkina O, M., & Eliashevich S, O. (2015). [Optimal Control Strategy Allies in Blood Pressure]. Kardiologiia, 55(3), 106-114. https://doi.org/10.18565/cardio.2015.3.106-114
Drapkina O, M, and Eliashevich S, O. "[Optimal Control Strategy Allies in Blood Pressure]." Kardiologiia vol. 55,3 (2015): 106-114. doi: https://doi.org/10.18565/cardio.2015.3.106-114
Drapkina O M, Eliashevich S O. [Optimal Control Strategy Allies in Blood Pressure]. Kardiologiia. 2015 Mar;55(3):106-114. doi: 10.18565/cardio.2015.3.106-114. Russian. PMID: 28294850.
Copy Download .nbib Format: NLM
Parameters of cutaneous microvasculature in men of working age with newly diagnosed arterial hypertension.

Clinical hemorheology and microcirculation

Korolev AI, Fedorovich AA, Gorshkov AY, Dadaeva VA, Kim OT, Omelyanenko KV, Mikhaylova MA, Vasilyev DK, Dzhioeva ON, Akasheva DU, Drapkina OM.
PMID: 34719487
Clin Hemorheol Microcirc. 2021 Oct 24; doi: 10.3233/CH-211292. Epub 2021 Oct 24.

OBJECTIVE: To investigate structural and functional features of cutaneous microvasculature in men of working age with newly diagnosed arterial hypertension (AH).MATERIALS AND METHODS: The study included 161 apparently healthy men from 30 to 60 years, who underwent a comprehensive...

Cite
Korolev AI, Fedorovich AA, Gorshkov AY, et al. Parameters of cutaneous microvasculature in men of working age with newly diagnosed arterial hypertension. Clin Hemorheol Microcirc. 2021;doi: 10.3233/CH-211292.
Korolev, A. I., Fedorovich, A. A., Gorshkov, A. Y., Dadaeva, V. A., Kim, O. T., Omelyanenko, K. V., Mikhaylova, M. A., Vasilyev, D. K., Dzhioeva, O. N., Akasheva, D. U., & Drapkina, O. M. (2021). Parameters of cutaneous microvasculature in men of working age with newly diagnosed arterial hypertension. Clinical hemorheology and microcirculation, . https://doi.org/10.3233/CH-211292
Korolev, A I, et al. "Parameters of cutaneous microvasculature in men of working age with newly diagnosed arterial hypertension." Clinical hemorheology and microcirculation vol. (2021). doi: https://doi.org/10.3233/CH-211292
Korolev AI, Fedorovich AA, Gorshkov AY, Dadaeva VA, Kim OT, Omelyanenko KV, Mikhaylova MA, Vasilyev DK, Dzhioeva ON, Akasheva DU, Drapkina OM. Parameters of cutaneous microvasculature in men of working age with newly diagnosed arterial hypertension. Clin Hemorheol Microcirc. 2021 Oct 24; doi: 10.3233/CH-211292. Epub 2021 Oct 24. PMID: 34719487.
Copy Download .nbib Format: NLM
Sudden gains among women receiving treatment for alcohol use disorders.

Addiction research & theory

Drapkin M, Epstein EE, McCrady B, Eddie D.
PMID: 33568968
Addict Res Theory. 2015;23(4):273-279. doi: 10.3109/16066359.2014.981809. Epub 2014 Nov 21.

Understanding the timing and types of change during treatment for mental health disorders is an important step toward elucidating possible mechanisms of behaviour change in response to therapeutic interventions, yet these issues have not been adequately addressed in the...

Cite
Drapkin M, Epstein EE, McCrady B, et al. Sudden gains among women receiving treatment for alcohol use disorders. Addict Res Theory. 2014;23(4):273-279doi: 10.3109/16066359.2014.981809.
Drapkin, M., Epstein, E. E., McCrady, B., & Eddie, D. (2015). Sudden gains among women receiving treatment for alcohol use disorders. Addiction research & theory, 23(4), 273-279. https://doi.org/10.3109/16066359.2014.981809
Drapkin, Michelle, et al. "Sudden gains among women receiving treatment for alcohol use disorders." Addiction research & theory vol. 23,4 (2015): 273-279. doi: https://doi.org/10.3109/16066359.2014.981809
Drapkin M, Epstein EE, McCrady B, Eddie D. Sudden gains among women receiving treatment for alcohol use disorders. Addict Res Theory. 2015;23(4):273-279. doi: 10.3109/16066359.2014.981809. Epub 2014 Nov 21. PMID: 33568968; PMCID: PMC7872146.
Copy Download .nbib Format: NLM
The Prevalence of Heterozygous Familial Hypercholesterolemia in Selected Regions of the Russian Federation: The FH-ESSE-RF Study.

Journal of personalized medicine

Meshkov AN, Ershova AI, Kiseleva AV, Shalnova SA, Drapkina OM, Boytsov SA, On Behalf Of The Fh-Esse-Rf Investigators.
PMID: 34074024
J Pers Med. 2021 May 24;11(6). doi: 10.3390/jpm11060464.

Heterozygous familial hypercholesterolemia (HeFH) is one of the most common genetic conditions but remains substantially underdiagnosed. The aim of our study was to investigate the prevalence of HeFH in the population of 11 different regions of Russia. Individuals were...

Cite
Meshkov AN, Ershova AI, Kiseleva AV, et al. The Prevalence of Heterozygous Familial Hypercholesterolemia in Selected Regions of the Russian Federation: The FH-ESSE-RF Study. J Pers Med. 2021;11(6)doi: 10.3390/jpm11060464.
Meshkov, A. N., Ershova, A. I., Kiseleva, A. V., Shalnova, S. A., Drapkina, O. M., Boytsov, S. A., & On Behalf Of The Fh-Esse-Rf Investigators. (2021). The Prevalence of Heterozygous Familial Hypercholesterolemia in Selected Regions of the Russian Federation: The FH-ESSE-RF Study. Journal of personalized medicine, 11(6), . https://doi.org/10.3390/jpm11060464
Meshkov, Alexey N, et al. "The Prevalence of Heterozygous Familial Hypercholesterolemia in Selected Regions of the Russian Federation: The FH-ESSE-RF Study." Journal of personalized medicine vol. 11,6 (2021). doi: https://doi.org/10.3390/jpm11060464
Meshkov AN, Ershova AI, Kiseleva AV, Shalnova SA, Drapkina OM, Boytsov SA, On Behalf Of The Fh-Esse-Rf Investigators. The Prevalence of Heterozygous Familial Hypercholesterolemia in Selected Regions of the Russian Federation: The FH-ESSE-RF Study. J Pers Med. 2021 May 24;11(6). doi: 10.3390/jpm11060464. PMID: 34074024; PMCID: PMC8225162.
Copy Download .nbib Format: NLM
[Efficacy and Safety of Rosuvastatin in Patients of Different Risk Groups of Developing Cardiovascular].

Kardiologiia

Drapkina OM, Eliashevich SO.
PMID: 28294815
Kardiologiia. 2015 Feb;55(2):72-81.

The purpose of the review - analysis of randomized clinical trials to evaluate the efficacy and safety of rosuvastatin in respect of primary and secondary prevention of cardiovascular events, as well as in patients with acute coronary syndrome. As...

Cite
Drapkina OM, Eliashevich SO. [Efficacy and Safety of Rosuvastatin in Patients of Different Risk Groups of Developing Cardiovascular]. Kardiologiia. 2015;55(2):72-81
Drapkina, O. M., & Eliashevich, S. O. (2015). [Efficacy and Safety of Rosuvastatin in Patients of Different Risk Groups of Developing Cardiovascular]. Kardiologiia, 55(2), 72-81.
Drapkina, O M, and Eliashevich, S O. "[Efficacy and Safety of Rosuvastatin in Patients of Different Risk Groups of Developing Cardiovascular]." Kardiologiia vol. 55,2 (2015): 72-81.
Drapkina OM, Eliashevich SO. [Efficacy and Safety of Rosuvastatin in Patients of Different Risk Groups of Developing Cardiovascular]. Kardiologiia. 2015 Feb;55(2):72-81. Russian. PMID: 28294815.
Copy Download .nbib Format: NLM
Treatment choices and subsequent attendance by substance-dependent patients who disengage from intensive outpatient treatment.

Addiction research & theory

Van Horn DH, Drapkin M, Lynch KG, Rennert L, Goodman JD, Thomas T, Ivey M, McKay JR.
PMID: 27667970
Addict Res Theory. 2015;23(5):391-403. doi: 10.3109/16066359.2015.1017570. Epub 2015 Apr 22.

In an effort to increase engagement in effective treatment, we offered a choice of alternate evidence-based treatments to 137 alcohol- or cocaine-dependent adults (110 males, 27 females) who entered an intensive outpatient program (IOP) but disengaged within the first...

Cite
Van Horn DH, Drapkin M, Lynch KG, et al. Treatment choices and subsequent attendance by substance-dependent patients who disengage from intensive outpatient treatment. Addict Res Theory. 2015;23(5):391-403doi: 10.3109/16066359.2015.1017570.
Van Horn, D. H., Drapkin, M., Lynch, K. G., Rennert, L., Goodman, J. D., Thomas, T., Ivey, M., & McKay, J. R. (2015). Treatment choices and subsequent attendance by substance-dependent patients who disengage from intensive outpatient treatment. Addiction research & theory, 23(5), 391-403. https://doi.org/10.3109/16066359.2015.1017570
Van Horn, Deborah H A, et al. "Treatment choices and subsequent attendance by substance-dependent patients who disengage from intensive outpatient treatment." Addiction research & theory vol. 23,5 (2015): 391-403. doi: https://doi.org/10.3109/16066359.2015.1017570
Van Horn DH, Drapkin M, Lynch KG, Rennert L, Goodman JD, Thomas T, Ivey M, McKay JR. Treatment choices and subsequent attendance by substance-dependent patients who disengage from intensive outpatient treatment. Addict Res Theory. 2015;23(5):391-403. doi: 10.3109/16066359.2015.1017570. Epub 2015 Apr 22. PMID: 27667970; PMCID: PMC5031141.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 26 entries